Europe Parkinson's Disease Market and Competitive Landscape - 2017

  • ID: 4377609
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Parkinson's Disease Market and Competitive Landscape - 2017, provides comprehensive insights into Parkinson's Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Parkinson's Disease market size and drug sales. This research also provides insights into Parkinson's Disease epidemiology and late stage pipeline.

The report is classified into nine sections - Parkinson's Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Parkinson's Disease pipeline insights covering late stage clinical trials pipeline; Parkinson's Disease prevalence trends by countries; Parkinson's Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Parkinson's Disease pipeline: Find out the drugs in clinical trials for Parkinson's Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Parkinson's Disease epidemiology: Find out the prevalence of Parkinson's Disease by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Parkinson's Disease products: Identify key products marketed and prescribed for Parkinson's Disease by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Parkinson's Disease market size: Find out the market size for Parkinson's Disease drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Parkinson's Disease drug sales: Find out the sales of Parkinson's Disease drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Parkinson's Disease drugs sales forecast: Sales forecast for Parkinson's Disease drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Parkinson's Disease market share analysis: Find out the market shares of Parkinson's Disease drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Parkinson's Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Parkinson's Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Parkinson's Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Parkinson's Disease: Disease Overview
1.1. Parkinson's Disease Symptoms
1.2. Parkinson's Disease Etiology
1.3. Parkinson's Disease Diagnosis
1.4. Parkinson's Disease Treatment Options

2. Parkinson's Disease Pipeline Insights
2.1. Parkinson's Disease Phase 3 Clinical Trials
2.2. Parkinson's Disease Phase 2 Clinical Trials
2.3. Parkinson's Disease Phase 1 Clinical Trials

3. Parkinson's Disease Epidemiology Analysis

4. Germany Parkinson's Disease Market Insights
4.1. Marketed Products for Parkinson's Disease in Germany
4.2. Germany Parkinson's Disease Market Size & Forecast
4.3. Germany Parkinson's Disease Product Sales Forecast
4.4. Germany Parkinson's Disease Market Share Analysis

5. France Parkinson's Disease Market Insights
5.1. Marketed Products for Parkinson's Disease in France
5.2. France Parkinson's Disease Market Size & Forecast
5.3. France Parkinson's Disease Product Sales Forecast
5.4. France Parkinson's Disease Market Share Analysis

6. Italy Parkinson's Disease Market Insights
6.1. Marketed Products for Parkinson's Disease in Italy
6.2. Italy Parkinson's Disease Market Size & Forecast
6.3. Italy Parkinson's Disease Product Sales Forecast
6.4. Italy Parkinson's Disease Market Share Analysis

7. Spain Parkinson's Disease Market Insights
7.1. Marketed Products for Parkinson's Disease in Spain
7.2. Spain Parkinson's Disease Market Size & Forecast
7.3. Spain Parkinson's Disease Product Sales Forecast
7.4. Spain Parkinson's Disease Market Share Analysis

8. UK Parkinson's Disease Market Insights
8.1. Marketed Products for Parkinson's Disease in UK
8.2. UK Parkinson's Disease Market Size & Forecast
8.3. UK Parkinson's Disease Product Sales Forecast
8.4. UK Parkinson's Disease Market Share Analysis

9. Europe Parkinson's Disease Market Insights
9.1. Europe Parkinson's Disease Market Size & Forecast
9.2. Europe Parkinson's Disease Product Sales Forecast
9.3. Europe Parkinson's Disease Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Parkinson's Disease Phase 3 Clinical Trials, Global, 2017
Table 2: Parkinson's Disease Phase 2 Clinical Trials, Global, 2017
Table 3: Parkinson's Disease Phase 1 Clinical Trials, Global, 2017
Table 4: Parkinson's Disease Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Parkinson's Disease in Germany, 2017
Table 6: Germany Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 8: Germany Parkinson's Disease Market Trends, 2012 - 2021
Table 9: Marketed Products for Parkinson's Disease in France, 2017
Table 10: France Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 12: France Parkinson's Disease Market Trends, 2012 - 2021
Table 13: Marketed Products for Parkinson's Disease in Italy, 2017
Table 14: Italy Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 16: Italy Parkinson's Disease Market Trends, 2012 - 2021
Table 17: Marketed Products for Parkinson's Disease in Spain, 2017
Table 18: Spain Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 20: Spain Parkinson's Disease Market Trends, 2012 - 2021
Table 21: Marketed Products for Parkinson's Disease in UK, 2017
Table 22: UK Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Parkinson's Disease Product Sales ($mn), 2012 - 2021
Table 24: UK Parkinson's Disease Market Trends, 2012 - 2021
Table 25: Europe Parkinson's Disease Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Parkinson's Disease Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Parkinson's Disease Pipeline by Phase (%), Global, 2017
Figure 2: Parkinson's Disease Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 4: Germany Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 5: Germany Parkinson's Disease Market Share by Products (%), 2016
Figure 6: Germany Parkinson's Disease Market - Future Market Share (%), 2021
Figure 7: France Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 8: France Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 9: France Parkinson's Disease Market Share by Products (%), 2016
Figure 10: France Parkinson's Disease Market - Future Market Share (%), 2021
Figure 11: Italy Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 12: Italy Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 13: Italy Parkinson's Disease Market Share by Products (%), 2016
Figure 14: Italy Parkinson's Disease Market - Future Market Share (%), 2021
Figure 15: Spain Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 16: Spain Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 17: Spain Parkinson's Disease Market Share by Products (%), 2016
Figure 18: Spain Parkinson's Disease Market - Future Market Share (%), 2021
Figure 19: UK Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 20: UK Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 21: UK Parkinson's Disease Market Share by Products (%), 2016
Figure 22: UK Parkinson's Disease Market - Future Market Share (%), 2021
Figure 23: Europe Parkinson's Disease Market Size ($mn), 2012 - 2021
Figure 24: Europe Parkinson's Disease Product Sales ($mn), 2012 - 2021
Figure 25: Europe Parkinson's Disease Market Share by Products (%), 2016
Figure 26: Europe Parkinson's Disease Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll